March 08, 2022
Today the Centers for Disease Control and Prevention (CDC) Division of Global HIV and TB released its 2021 Annual Program Results, presenting an array of impressive data that demonstrate the agency’s impact in fighting infectious diseases.
As part of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the CDC and its partners work to combat the global HIV and tuberculosis (TB) epidemics.
According to the CDC’s 2021 APR,
- CDC-funded programs support 62 percent of all people served by PEPFAR.
- Of the 18.9 million PEPFAR-supported men, women, and children on lifesaving antiretroviral therapy (ART), 11.8 million are directly supported by the CDC and their partners.
- Of the 2.4 million people newly identified as living with HIV through testing services, 1.5 million were from CDC and their partners.
The University of Maryland, Baltimore (UMB), the institution in which Ciheb was founded, began PEPFAR-related work in 2004, and is a proud CDC partner. The 2021 APR numbers are a great reminder of this important work’s impact.
The CDC website features a blog that details how its PEPFAR-related work helps people on an individual level. Their stories offer a snapshot into PEPFAR- and CDC-related work, and how that work affects those living with HIV and TB.
Contact
Center for International Health, Education, and Biosecurity
Institute of Human Virology
Tyler New
Scientific Writer
tnew@ihv.umaryland.edu
Related stories
Tuesday, May 03, 2022
Training on Data Use for HIV Program Management in Nigeria
To build the capacity of the UMB Surge staff to better perform their roles – presenting data with enhanced clarity for decision-making – the Center for International Health, Education, and Biosecurity (Ciheb) Nigeria conducted a 5-day training workshop from March 14 to 18 in Lagos, Nigeria.